Daniel Heilpern-Mallory

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma”.

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

Cancer Cell(2022)10.1016/j.ccell.2022.10.017

N/A

0.626DataRank · unranked

64 citations

Michelle P. Aranha, Robert Redd, Joanna Bagińska, Nicholas J. Haradhvala, Margaret Hallisey +34 more

Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma

Cancer Research(2024)10.1158/0008-5472.can-24-1440

N/A

0.386DataRank · unranked

7 citations

Kendell Clement, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, Rohan Kodgule, Charles P. Fulco +9 more

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.01.551480

N/A

0DataRank · unranked

2 citations

Elizabeth D. Lightbody, Mairéad Reidy, Junko Tsuji, Michelle P. Aranha, Daniel Heilpern-Mallory +15 more

Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia

Nature Communications(2025)10.1038/s41467-025-56323-w

N/A

0DataRank · unranked

13 citations

Yoshinobu Konishi, Daniel Heilpern-Mallory, Ting Wu, Nicholas Tsakmaklis, Michelle P. Aranha +17 more